Atalanta Sosnoff Capital Lowered Cvs Health (CVS) Holding By $2.12 Million; Cambridge Financial Group Has Increased By $43.15 Million Its Bank Of America (BAC) Position

Cambridge Financial Group Inc increased Bank Of America Corp (BAC) stake by 0.75% reported in 2017Q3 SEC filing. Cambridge Financial Group Inc acquired 1,703 shares as Bank Of America Corp (BAC)’s stock declined 6.00%. The Cambridge Financial Group Inc holds 227,989 shares with $5.78B value, up from 226,286 last quarter. Bank Of America Corp now has $322.47 billion valuation. The stock decreased 1.56% or $0.5 during the last trading session, reaching $31.48. About 90.55M shares traded or 18.97% up from the average. Bank of America Corporation (NYSE:BAC) has risen 58.64% since March 2, 2017 and is uptrending. It has outperformed by 41.94% the S&P500.

Atalanta Sosnoff Capital Llc decreased Cvs Health Corp (CVS) stake by 79.96% reported in 2017Q3 SEC filing. Atalanta Sosnoff Capital Llc sold 26,220 shares as Cvs Health Corp (CVS)’s stock declined 4.23%. The Atalanta Sosnoff Capital Llc holds 6,570 shares with $534,000 value, down from 32,790 last quarter. Cvs Health Corp now has $68.12 billion valuation. The stock decreased 0.86% or $0.58 during the last trading session, reaching $67.15. About 9.56 million shares traded. CVS Health Corporation (NYSE:CVS) has declined 24.40% since March 2, 2017 and is downtrending. It has underperformed by 41.10% the S&P500.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on May, 1. They expect $1.40 EPS, up 19.66% or $0.23 from last year’s $1.17 per share. CVS’s profit will be $1.42 billion for 11.99 P/E if the $1.40 EPS becomes a reality. After $1.92 actual EPS reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts -27.08% negative EPS growth.

Since September 11, 2017, it had 0 insider purchases, and 6 sales for $39.50 million activity. 237,078 shares valued at $18.88 million were sold by Denton David M on Monday, September 11. Another trade for 19,965 shares valued at $1.42 million was made by Foulkes Helena on Friday, February 16. 85,743 shares were sold by Roberts Jonathan C, worth $7.13M. Moriarty Thomas M also sold $7.19M worth of CVS Health Corporation (NYSE:CVS) on Monday, September 11.

Investors sentiment decreased to 0.88 in 2017 Q3. Its down 0.04, from 0.92 in 2017Q2. It is negative, as 60 investors sold CVS shares while 571 reduced holdings. 88 funds opened positions while 466 raised stakes. 801.45 million shares or 0.31% less from 803.96 million shares in 2017Q2 were reported. Tcw Group Inc, a California-based fund reported 866,946 shares. Nordea Invest Management Ab reported 2.76% stake. Cypress Asset Management Tx holds 0.41% in CVS Health Corporation (NYSE:CVS) or 23,450 shares. Bnp Paribas Asset Mgmt Sa has invested 0.42% in CVS Health Corporation (NYSE:CVS). Whalerock Point Ltd owns 34,201 shares. Rench Wealth reported 0.88% stake. Massachusetts-based Fayerweather Charles has invested 3.39% in CVS Health Corporation (NYSE:CVS). Country Club Na holds 82,617 shares or 0.92% of its portfolio. Cypress Cap Limited Liability Corp owns 14,374 shares or 0.25% of their US portfolio. Kbc Grp Nv has invested 0.38% in CVS Health Corporation (NYSE:CVS). Mackenzie Fincl, a Ontario – Canada-based fund reported 1.10M shares. Amp Invsts, a Australia-based fund reported 483,705 shares. Clifford Swan Inv Counsel Ltd Co holds 0.03% or 5,535 shares in its portfolio. Meiji Yasuda Life Ins owns 36,647 shares for 0.44% of their portfolio. Of Virginia Va owns 88,634 shares.

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health had 73 analyst reports since July 22, 2015 according to SRatingsIntel. The stock has “Hold” rating by Jefferies on Wednesday, August 16. The firm earned “Buy” rating on Monday, August 10 by Argus Research. On Thursday, March 10 the stock rating was reinitiated by Barclays Capital with “Overweight”. Tigress Financial maintained the shares of CVS in report on Tuesday, December 26 with “Buy” rating. The rating was maintained by RBC Capital Markets with “Buy” on Monday, December 4. The firm has “Buy” rating by Leerink Swann given on Tuesday, November 21. Robert W. Baird downgraded CVS Health Corporation (NYSE:CVS) on Thursday, February 2 to “Neutral” rating. The stock of CVS Health Corporation (NYSE:CVS) earned “Outperform” rating by Leerink Swann on Tuesday, November 7. Jefferies maintained it with “Buy” rating and $122 target in Thursday, May 12 report. The stock of CVS Health Corporation (NYSE:CVS) earned “Hold” rating by Jefferies on Friday, June 9.

Atalanta Sosnoff Capital Llc increased Fedex Corp (NYSE:FDX) stake by 2,605 shares to 204,418 valued at $46.11 million in 2017Q3. It also upped Home Depot Inc (NYSE:HD) stake by 2,472 shares and now owns 437,048 shares. Visa Inc Cl A (NYSE:V) was raised too.

Cambridge Financial Group Inc decreased Sysco Corp (NYSE:SYY) stake by 107,720 shares to 111,687 valued at $6.03B in 2017Q3. It also reduced Assurant Inc. (NYSE:AIZ) stake by 289 shares and now owns 62,241 shares. Guggenheim Etf Equal Weight (RSP) was reduced too.

Among 33 analysts covering Bank of America (NYSE:BAC), 22 have Buy rating, 0 Sell and 11 Hold. Therefore 67% are positive. Bank of America has $37 highest and $15 lowest target. $26.24’s average target is -16.65% below currents $31.48 stock price. Bank of America had 106 analyst reports since July 21, 2015 according to SRatingsIntel. Robert W. Baird downgraded the shares of BAC in report on Wednesday, November 16 to “Neutral” rating. The rating was downgraded by Citigroup on Tuesday, April 4 to “Neutral”. The stock has “Buy” rating by Nomura on Tuesday, July 18. Macquarie Research upgraded Bank of America Corporation (NYSE:BAC) on Thursday, February 16 to “Outperform” rating. BMO Capital Markets maintained it with “Hold” rating and $34.0 target in Wednesday, January 17 report. As per Thursday, September 14, the company rating was maintained by Jefferies. The stock has “Buy” rating by RBC Capital Markets on Wednesday, April 5. The firm has “Buy” rating given on Tuesday, September 1 by Bernstein. Sandler O’Neill maintained Bank of America Corporation (NYSE:BAC) rating on Tuesday, January 9. Sandler O’Neill has “Buy” rating and $34.0 target. BMO Capital Markets maintained Bank of America Corporation (NYSE:BAC) on Tuesday, July 18 with “Hold” rating.

Investors sentiment decreased to 1.04 in 2017 Q3. Its down 0.08, from 1.12 in 2017Q2. It is negative, as 68 investors sold BAC shares while 569 reduced holdings. 117 funds opened positions while 547 raised stakes. 6.91 billion shares or 9.01% more from 6.34 billion shares in 2017Q2 were reported. Buckingham Asset Mgmt Limited Liability reported 0.27% in Bank of America Corporation (NYSE:BAC). 1.29M are owned by Kayne Anderson Rudnick Investment Mgmt Limited Com. Moneta Advsr Limited Liability Company stated it has 33,298 shares. Bridgeway Capital Management Inc owns 4.33M shares for 1.25% of their portfolio. Lenox Wealth Mgmt Incorporated reported 3,841 shares or 0.03% of all its holdings. Aristotle Capital Limited Liability Com owns 15.68 million shares. Sumitomo Life Ins has 382,870 shares. Parallax Volatility Advisers Ltd Partnership stated it has 0.07% of its portfolio in Bank of America Corporation (NYSE:BAC). Cullen Frost Bankers Inc holds 0.57% of its portfolio in Bank of America Corporation (NYSE:BAC) for 681,514 shares. Moreover, Golub Limited Liability has 3.33% invested in Bank of America Corporation (NYSE:BAC). Shoker Counsel Inc holds 0.33% or 17,342 shares. Marshwinds Advisory holds 0.46% of its portfolio in Bank of America Corporation (NYSE:BAC) for 39,459 shares. Chicago Equity Llc invested 1.12% of its portfolio in Bank of America Corporation (NYSE:BAC). Ironwood Financial Limited Liability Com holds 0.01% of its portfolio in Bank of America Corporation (NYSE:BAC) for 800 shares. Letko Brosseau Assoc invested in 2.08% or 9.08M shares.